Stefan K James

Summary

Affiliation: University Hospital
Country: Sweden

Publications

  1. ncbi request reprint Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy)
    Stefan K James
    Department of Medical Sciences and Cardiology, Academic Hospital, Uppsala, Sweden
    Am J Cardiol 97:167-72. 2006
  2. ncbi request reprint Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy
    Stefan K James
    Department of Medical Sciences Cardiology, Thoraxcenter, Academic Hospital, 751 85 Uppsala, Sweden
    J Am Coll Cardiol 41:916-24. 2003
  3. ncbi request reprint N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (
    Stefan K James
    Department of Medical Sciences, Cardiology, University of Uppsala, Uppsala, Sweden
    Circulation 108:275-81. 2003
  4. ncbi request reprint Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial
    Stefan James
    Department of Cardiology, Uppsala University Hospital, Uppsala, Sweden
    Am J Med 115:178-84. 2003
  5. ncbi request reprint A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes
    Stefan K James
    Department of Medical Sciences, Cardiology, Uppsala, Sweden
    Int J Cardiol 93:113-20. 2004
  6. ncbi request reprint Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy
    Stefan K James
    Uppsala Clinical Research Center, Uppsala, Sweden
    J Am Coll Cardiol 48:1146-54. 2006
  7. doi request reprint Safety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes mellitus: long-term follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
    Ulf Stenestrand
    Department of Cardiology, University Hospital, 581 85 Linkoping, Sweden
    Eur Heart J 31:177-86. 2010
  8. doi request reprint Outcome and causes of renal deterioration evaluated by serial cystatin C measurements in acute coronary syndrome patients -- results from the PLATelet inhibition and patient Outcomes (PLATO) study
    Axel Akerblom
    Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden
    Am Heart J 164:728-34. 2012
  9. doi request reprint Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry)
    Ole Frobert
    Department of Cardiology, Orebro University Hospital, Orebro, Sweden
    J Am Coll Cardiol 53:1660-7. 2009
  10. doi request reprint Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden
    Stefan K James
    Department of Cardiology, Uppsala University Hospital, Uppsala, Sweden
    N Engl J Med 360:1933-45. 2009

Detail Information

Publications28

  1. ncbi request reprint Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy)
    Stefan K James
    Department of Medical Sciences and Cardiology, Academic Hospital, Uppsala, Sweden
    Am J Cardiol 97:167-72. 2006
    ..Despite a larger proportion of ST depression and increased levels of NT-pro-BNP and interleukin-6 at admission, these factors provide independent prognostic information that may improve risk stratification and guidance of treatment...
  2. ncbi request reprint Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy
    Stefan K James
    Department of Medical Sciences Cardiology, Thoraxcenter, Academic Hospital, 751 85 Uppsala, Sweden
    J Am Coll Cardiol 41:916-24. 2003
    ..We sought to evaluate C-reactive protein (CRP) and troponin T (TnT) as predictors of risk of the individual end points of mortality and myocardial infarction (MI) in a large cohort of patients with acute coronary syndrome (ACS)...
  3. ncbi request reprint N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (
    Stefan K James
    Department of Medical Sciences, Cardiology, University of Uppsala, Uppsala, Sweden
    Circulation 108:275-81. 2003
    ....
  4. ncbi request reprint Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial
    Stefan James
    Department of Cardiology, Uppsala University Hospital, Uppsala, Sweden
    Am J Med 115:178-84. 2003
    ..However, the appropriate cutoff for identifying patients with the acute coronary syndrome who are at low risk of subsequent mortality has not been established...
  5. ncbi request reprint A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes
    Stefan K James
    Department of Medical Sciences, Cardiology, Uppsala, Sweden
    Int J Cardiol 93:113-20. 2004
    ..Troponin is a specific marker of myocardial damage. For early prediction of coronary events in patients with suspicion of acute coronary syndromes the assay also needs to be highly sensitive...
  6. ncbi request reprint Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy
    Stefan K James
    Uppsala Clinical Research Center, Uppsala, Sweden
    J Am Coll Cardiol 48:1146-54. 2006
    ..This study was designed to evaluate biomarkers for selection of patients with non-ST-segment elevation acute coronary syndromes (ACS) that derive mortality benefit from revascularization...
  7. doi request reprint Safety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes mellitus: long-term follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
    Ulf Stenestrand
    Department of Cardiology, University Hospital, 581 85 Linkoping, Sweden
    Eur Heart J 31:177-86. 2010
    ..Patients with diabetes mellitus have more extensive coronary artery disease, more disease progression, and restenosis. The use of drug-eluting stents (DES) in these patients is widespread, despite uncertain long-term safety and efficacy...
  8. doi request reprint Outcome and causes of renal deterioration evaluated by serial cystatin C measurements in acute coronary syndrome patients -- results from the PLATelet inhibition and patient Outcomes (PLATO) study
    Axel Akerblom
    Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden
    Am Heart J 164:728-34. 2012
    ....
  9. doi request reprint Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry)
    Ole Frobert
    Department of Cardiology, Orebro University Hospital, Orebro, Sweden
    J Am Coll Cardiol 53:1660-7. 2009
    ..Our aim was to evaluate restenosis rate of drug-eluting stents (DES) in patients with and without diabetes mellitus (DM) in a real-world setting...
  10. doi request reprint Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden
    Stefan K James
    Department of Cardiology, Uppsala University Hospital, Uppsala, Sweden
    N Engl J Med 360:1933-45. 2009
    ..The long-term safety and efficacy of drug-eluting coronary stents have been questioned...
  11. ncbi request reprint Activation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST-elevation acute coronary syndromes treated with dalteparin: a GUSTO IV substudy
    Stefan K James
    Department of Medical Sciences, Cardiology, Thoraxcenter, Academic Hospital, Uppsala, Sweden
    Am Heart J 147:267-74. 2004
    ..In addition to platelet inhibition, recent evidence suggests that the glycoprotein IIb/IIIa receptor inhibitor abciximab attenuates inflammation and coagulation activity...
  12. doi request reprint Eptifibatide is noninferior to abciximab in primary percutaneous coronary intervention: results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry)
    Axel Akerblom
    Department of Cardiology, UppsalaClinical Research Center, Uppsala University, Uppsala, Sweden
    J Am Coll Cardiol 56:470-5. 2010
    ..The aim of this study was to test the noninferiority of eptifibatide relative to abciximab in patients with ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI)...
  13. ncbi request reprint Population trends in percutaneous coronary intervention: 20-year results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry)
    Marieke L Fokkema
    Thoraxcenter, Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    J Am Coll Cardiol 61:1222-30. 2013
    ..The aim of this study was to describe the characteristics and outcome of all consecutive patients treated with percutaneous coronary intervention (PCI) in an unselected nationwide cohort over the past 2 decades...
  14. doi request reprint Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST-elevation acute coronary syndromes: results from the Platelet Inhibition and Patient Outcomes study
    Axel Akerblom
    Department of Medical Sciences, Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden
    Clin Chem 58:190-9. 2012
    ....
  15. ncbi request reprint An acute inflammatory reaction induced by myocardial damage is superimposed on a chronic inflammation in unstable coronary artery disease
    Stefan K James
    The Research Group of Cardiology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    Am Heart J 149:619-26. 2005
    ..Inflammation plays an important role in unstable coronary artery disease (CAD). We assessed the kinetics of inflammatory markers from symptom onset in patients with unstable CAD and their relation to myocardial damage...
  16. doi request reprint Thrombus aspiration during ST-segment elevation myocardial infarction
    Ole Frobert
    From the Department of Cardiology, Orebro University Hospital, Örebro O F, F C, Department of Medical Sciences, Cardiology, and Uppsala Clinical Research Center, Uppsala University, Uppsala B L, O O, S K J, Department of Cardiology, Lund University Hospital, Lund G K O, D E, J H, Department of Cardiology, Sahlgrenska University Hospital, Gothenburg E O, O A, Department of Cardiology, Karolinska Institutet, Sodersjukhuset M A, and Cardiology Unit, Department of Medicine, Karolinska University Hospital U J, Stockholm, Department of Cardiology, Karlstad Hospital, Karlstad M D, Department of Cardiology, Gavle Hospital, Gävle L H, PCI unit, Sunderby Hospital, Sunderby A C J, Department of Cardiology, Västerås Hospital, Västerås A K, Department of Cardiology, Heart Center
    N Engl J Med 369:1587-97. 2013
    ..We aimed to evaluate whether thrombus aspiration reduces mortality...
  17. doi request reprint Stent thrombosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty Registry
    Bo Lagerqvist
    Uppsala Clinical Research Centre, Uppsala University Hospital, Uppsala, Sweden
    Circ Cardiovasc Interv 2:401-8. 2009
    ..The objective was to evaluate the role of risk factors and stent type for stent thrombosis (ST) using a large real world registry...
  18. doi request reprint Cystatin C- and creatinine-based estimates of renal function and their value for risk prediction in patients with acute coronary syndrome: results from the PLATelet Inhibition and Patient Outcomes (PLATO) study
    Axel Akerblom
    Department of Medical Sciences, Cardiology, Uppsala University, Uppsala Sweden
    Clin Chem 59:1369-75. 2013
    ..We evaluated 2 different cystatin C assays, alone or combined with creatinine, in patients with acute coronary syndrome...
  19. pmc Effect of stent inflation pressure and post-dilatation on the outcome of coronary artery intervention. A report of more than 90,000 stent implantations
    Ole Frobert
    Department of Cardiology, Orebro University Hospital, Orebro, Sweden
    PLoS ONE 8:e56348. 2013
    ..Using comprehensive registry data our aim was to evaluate how stent inflation pressure influences restenosis, stent thrombosis and death following PCI...
  20. doi request reprint Thrombus Aspiration in ST-Elevation myocardial infarction in Scandinavia (TASTE trial). A multicenter, prospective, randomized, controlled clinical registry trial based on the Swedish angiography and angioplasty registry (SCAAR) platform. Study design and
    Ole Frobert
    Department of Cardiology, Orebro University Hospital, Orebro, Sweden
    Am Heart J 160:1042-8. 2010
    ..Thrombus aspiration is widely used in clinical practice and is recommended by international guidelines despite limited evidence...
  21. doi request reprint Long-term safety and efficacy of drug-eluting and bare metal stents in saphenous vein grafts
    Ole Frobert
    Department of Cardiology, Orebro University Hospital, Sweden
    Am Heart J 164:87-93. 2012
    ..Long-term safety and efficacy data of drug-eluting stents (DESs) in saphenous vein grafts (SVGs) are lacking. This study sought to compare the clinical outcomes of DES versus bare metal stents (BMS) in SVGs...
  22. ncbi request reprint Lipoprotein-associated phospholipase A2 does not predict mortality or new ischaemic events in acute coronary syndrome patients
    Jonas Oldgren
    Uppsala Clinical Research Center, Uppsala University Hospital, Uppsala, Sweden
    Eur Heart J 28:699-704. 2007
    ....
  23. doi request reprint Biomarkers in Relation to the Effects of Ticagrelor in Comparison With Clopidogrel in Non-ST-Elevation Acute Coronary Syndrome Patients Managed With or Without In-Hospital Revascularization: A Substudy From the Prospective Randomized Platelet Inhibition a
    Lars Wallentin
    Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden L W, D L, L W, C H, S K J Department of Medical Sciences, Clinical Chemistry and Uppsala Clinical Research Center Uppsala University, Uppsala, Sweden A S Division of Cardiovascular Health and Disease, Heart, Lung and Vascular Institute, Academic Health Center, Cincinnati, OH R C B Department of Medicine, Stanford University, Stanford, CA R A H, K W M TIMI Study Group, Cardiovascular Division, Brigham and Women s Hospital, Boston, MA C P C Department of Cardiology, Medisch Centrum Alkmaar, Alkmaar, Netherlands J H C AstraZeneca Research and Development, Molndal, Sweden A H Medizinische Klinik, Universitatsklinikum Heidelberg, Heidelberg, Germany E G, H A K Medical Department, Hospital Unit West, Herning Holstbro, Denmark S H INSERM Unité 698, Paris, Department of Biochemistry
    Circulation 129:293-303. 2014
    ....
  24. doi request reprint Ticagrelor versus clopidogrel in patients with acute coronary syndromes and a history of stroke or transient ischemic attack
    Stefan K James
    Department of Medical Sciences, Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden
    Circulation 125:2914-21. 2012
    ..Patients with acute coronary syndromes and history of stroke or transient ischemic attack (TIA) have an increased rate of recurrent cardiac events and intracranial hemorrhages...
  25. ncbi request reprint Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden
    Bo Lagerqvist
    Uppsala Clinical Research Center, Uppsala University Hospital, Uppsala, Sweden
    N Engl J Med 356:1009-19. 2007
    ..Recent reports have indicated that there may be an increased risk of late stent thrombosis with the use of drug-eluting stents, as compared with bare-metal stents...
  26. doi request reprint Proximal coronary artery intervention: stent thrombosis, restenosis and death
    Fredrik Calais
    Department of Cardiology, Orebro University Hospital, Orebro, Sweden
    Int J Cardiol 170:227-32. 2013
    ....
  27. doi request reprint ST2 and mortality in non-ST-segment elevation acute coronary syndrome
    Kai M Eggers
    Department of Medical Sciences, Uppsala University, Sweden
    Am Heart J 159:788-94. 2010
    ....
  28. doi request reprint Treatment Patterns and Outcomes in Patients Undergoing Percutaneous Coronary Intervention Treated With Prasugrel or Clopidogrel (from the Swedish Coronary Angiography and Angioplasty Registry [SCAAR])
    Peter Damman
    Department of Medical Sciences, Cardiology, and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden Academic Medical Center University of Amsterdam, Amsterdam, The Netherlands Electronic address
    Am J Cardiol 113:64-9. 2014
    ..Mortality and bleeding rates were lower with prasugrel than clopidogrel, probably because of patient selection. ..